| MNs | microneedles |
| API | active pharmaceutical ingredients |
| u-MNs | uncoated microneedles |
| c-MNs | coated microneedles |
| r-MNs | microneedles with coated formulation removed |
| u-L-MNs | uncoated microneedles with low aspect ratio |
| u-M-MNs | uncoated microneedles with medium aspect ratio |
| u-H-MNs | uncoated microneedles with high aspect ratio |
| c-L-MNs | coated microneedles with low aspect ratio |
| c-M-MNs | coated microneedles with medium aspect ratio |
| c-H-MNs | coated microneedles with high aspect ratio |
| r-L-MNs | microneedles with coated formulation removed with low aspect ratio |
| r-M-MNs | microneedles with coated formulation removed with medium aspect ratio |
| r-H-MNs | microneedles with coated formulation removed with high aspect ratio |